Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities.

ABSTRACT:

Purpose

A panel of international experts proposed a new definition of fatty liver in 2020, namely metabolic dysfunction-associated fatty liver disease (MAFLD). As an adipokine, adipsin is closely related to metabolic-related diseases. In this study, we aimed to evaluate the relationship among MAFLD, serum adipsin, and metabolic risk abnormalities.

Methods

Our study was a cross-sectional study based on the first follow-up of the Guangzhou Nutrition and Health Study (GNHS). A total of 908 patients with hepatic steatosis were involved in our study. Detailed data of patients were collected based upon questionnaire information, physical examination, and blood biochemical test.

Results

Among the 908 patients, 789 patients were diagnosed with MAFLD. The levels of serum adips

SUBMITTER: Pan J 

PROVIDER: S-EPMC9882414 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature